CARE

CARE, short for Collaborative Action for SARS-CoV-2 Eradication, is a Texas nonprofit organization formed in 2020 in response to the COVID-19 pandemic. The organization appears to combine pandemic-focused medical research with healthcare relief and telehealth support initiatives, particularly connecting U.S.-based physicians with clinicians in India. Public materials indicate it pursued a clinical study of imiquimod cream in combination with hydroxychloroquine for COVID-19 prophylaxis and early intervention, while also coordinating oxygen concentrators, BiPAP machines, PPE, and medical advisory support. CARE has also been described as working on COVID tracking, mutation tracking, and data-driven research efforts. Overall, it looks more like a mission-driven nonprofit healthcare and medical research entity than a traditional venture-backed biotech or pharmaceutical company.